Enamine is a leading provider of chemistry and biology services, boasting the world's largest catalog of building blocks and screening compounds. The company specializes in custom synthesis and offers a vast array of over 300,000 compounds in stock, including more than 60 pre-plated compound libraries. Enamine's advanced capabilities in computer-aided drug design (CADD) and virtual chemical space exploration allow for the rapid identification and development of new active molecules. Their unique synthesis technologies and a team of over 650 skilled chemists enable the synthesis of approximately 2,000 new building blocks each month, enhancing their offerings in medicinal chemistry.

In collaboration with Chemspace, Enamine has significantly expanded its drug discovery platform, providing access to an ultra-large virtual chemical space that exceeds 2.7 trillion REAL compounds. This partnership aims to leverage advanced computational methods, including machine learning and chemoinformatics, to optimize the hit-finding process and enhance the identification of promising drug candidates. By combining their resources and expertise, Enamine and Chemspace are poised to accelerate the discovery of potent compounds with favorable pharmacokinetic profiles, ultimately contributing to breakthroughs in medical research and drug development.

Ukraine

Enamine has developed the world's largest reputable collection of chemical compounds, carefully designed and produced for Life Science industries. 
Stock collections: 4M+ screening compounds, 250k+ fragments, 300k+ building blocks. 
Comprehensive services in lead discovery and optimization are available including integrated biomolecular and ADME/TOX screening, all on-site.

Enamine

Company Details